# Carbon Monoxide in an Experimental Model of Chronic Pelvic Pain Syndrome: The Effects of CORM-A1 on Pain and Anxiety-Related Behaviors

**Authors:** Nikola Šutulović, Neriman Ezgin, Nela Puškaš, Emilija Đurić, Željko Grubač, Daniel Škrijelj, Milena Vesković, Dušan Mladenović, Isidora Savić, Djuro Macut, Yavuz Dodurga, Aleksandra Rašić-Marković, Olivera Stanojlović, Dragan Hrnčić

PMC · DOI: 10.3390/pathophysiology32040053 · Pathophysiology · 2025-10-01

## TL;DR

This study shows that CORM-A1 reduces pain and anxiety in a rat model of chronic pelvic pain syndrome.

## Contribution

The novel contribution is demonstrating CORM-A1's analgesic and anxiolytic effects in a CP/CPPS experimental model.

## Key findings

- CORM-A1 increased pain thresholds in CP/CPPS rats (p < 0.001).
- CORM-A1 improved anxiety-like behaviors in multiple tests (p < 0.001–0.01).
- Carrageenan-induced CP/CPPS caused significant prostate damage and hypersensitivity.

## Abstract

Current standard treatments for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a urological disorder with anxiety as a major comorbidity, are limited in success rates. Recent findings revealed the anti-inflammatory and neuroprotective effects of CO-releasing molecules (CO-RMs), but there is a gap in the knowledge on its effects in CP/CPPS. Therefore, the objective of our study was to investigate the potential therapeutic effects of CORM-A1 on the scrotal pain threshold and anxiety-related behaviors in experimental model of CP/CPPS. Adult Wistar albino male rats were randomized to Sham (intraprostatic saline) or CP/CPPS (intraprostatic λ-carrageenan) groups (n = 12). Half received CORM-A1 (2 mg/kg/day, i.p., days 1–7), others PBS, forming four subgroups (n = 6). The pain threshold (by an electronic von Frey esthesiometer) and anxiety-like behavior (by an open field, elevated plus maze and light/dark test) were assessed; prostates were histologically examined. Carrageenan-induced CP/CPPS caused significant mechanical pain hypersensitivity (p < 0.001), anxiety-like behaviors (p < 0.001–0.05), and histological prostate damage when compared to corresponding Sham groups. CORM-A1 treatment increased pain thresholds (p < 0.001) and improved behavioral outcomes (p < 0.001–0.01) in all ethological tests. These findings indicate that CORM-A1 exerts analgesic and anxiolytic effects in an experimental model of CP/CPPS in rats.

## Linked entities

- **Chemicals:** CORM-A1 (PubChem CID 136951470), saline (PubChem CID 5234)
- **Diseases:** anxiety (MONDO:0005618)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), Pain (MESH:D010146), urological disorder (MESH:D014570), CP (MESH:D002972), Anxiety (MESH:D001007), prostate damage (MESH:D011469), Chronic Pelvic Pain Syndrome (MESH:D011472)
- **Chemicals:** Carrageenan (MESH:D002351), PBS (MESH:D007854), Carbon Monoxide (MESH:D002248), CPPS (MESH:C014896), CORM-A1 (MESH:C503854), CO-RMs (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12551041/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12551041/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12551041/full.md

---
Source: https://tomesphere.com/paper/PMC12551041